(19)
(11) EP 2 629 609 A2

(12)

(88) Date of publication A3:
02.08.2012

(43) Date of publication:
28.08.2013 Bulletin 2013/35

(21) Application number: 11835022.2

(22) Date of filing: 18.10.2011
(51) International Patent Classification (IPC): 
A01N 37/12(2006.01)
A61K 31/195(2006.01)
A01N 37/44(2006.01)
(86) International application number:
PCT/US2011/056771
(87) International publication number:
WO 2012/054528 (26.04.2012 Gazette 2012/17)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 19.10.2010 US 394716 P
19.10.2010 US 394732 P
07.01.2011 US 201161430914 P

(71) Applicant: Elcelyx Therapeutics, Inc.
San Diego, CA 92130 (US)

(72) Inventors:
  • BARON, Alain, D.
    San Diego, CA 92130 (US)
  • BROWN, Martin, R.
    Coronado, CA 92118 (US)
  • JONES, Christopher, R.G.
    San Diego, CA 92129 (US)
  • BEELEY, Nigel, R.A.
    Solana Beach, CA 92075 (US)

(74) Representative: Ricker, Mathias 
Wallinger Ricker Schlotter Tostmann Patent- und Rechtsanwälte Zweibrückenstraße 5-7
80331 München
80331 München (DE)

   


(54) CHEMOSENSORY RECEPTOR LIGAND-BASED THERAPIES